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ABSTRACT
Pieces of fetal rat lumbar spinal cord were
transplanted into the anterior eye chamber of adult
rat hosts. At least seven months later, extracellular
single-unit recordings of spontaneously active graft
neurons were made prior to and during the
superfusion of either glutamate or -aminobutyric
acid (GABA). Superfusion of glutamate produced an
increase (five cells), decrease (three cells), or had no
effect (two cells) on the firing rate of neurons tested.
Superfusion of GABA decreased the firing rate of all
twelve neurons tested, while superfusion of the GABA
receptor antagonist bicuculline increased the firing
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rates of all eight neurons tested. The latency and
magnitude of the responses to glutamate and GABA
were not related to depth of the recording electrode
below the graft surface. Together, these data suggest
that the intraocular spinal cord graft is suitable for
the in vivo study of GABA and glutamate neuro-
pharmacology.
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INTRODUCTION
Fetal rat spinal cord tissue will develop in the anterior
eye chamber of adult rat hosts/15,29,39/. The grafts
are quickly vascularized by the host iris, increase in
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size for the first six weeks in the eye, and maintain
their general appearance for the life of the host
/15,34/. Using this h vivo preparation, the growth
/15,19/, organotypical development /16,17/ and
cellular organization /6,15/ of isolated spinal cord
neurons have been studied.
Dissociated fetal spinal cord tissue cultures are
routinely used to characterize neurotransmitter action
in vitro /36/. There are, however, advantages to be
gained by using intraocular grafts for such studies.
First, the tissue is not dissociated prior to trans-
plantation, resulting in the preservation of some
neuronal organization. We have shown that neurons in
intraocular spinal cord grafts are in many ways similar
in appearance and organization to neurons in the
intact spinal cord /6/. This contrasts with cultured
spinal cord neurons, which develop neurites /32/ that
do not resemble dendrites and axons in situ. Second,
intraocular spinal cord grafts are nourished by the
host’s blood supply via a dense capillary network/6/
originating from the ground plexus of the host iris
/15/. This is in contrast to the artificial medium which
is fed to cultured spinal cord neurons or slice
preparations. Third, intraocular grafts provide a means
to study transplanted tissue for long time periods after
manipulations of blood constituents or anterior eye
chamber fluid.A previous study has described changes
in the growth of spinal cord grafts after intravenous
administration of thyrotropin releasing hormone to the
adult hosts /19/. Also, colchicine has been injected
into the anterior eye chamber several weeks after
tissue transplantation in order to visualize neuro-
peptides in graft cell bodies /16/. These studies
indicate that intraocular grafts provide a flexible model
system to study neurotransmitter actions of developing
tissue transplanted to the eye from different regions of
the central nervous system, including the spinal cord.
Previous electrophysiological studies have shown that
spinal cord graft neurons respond to norepinephrine
/14/and serotonin/18/. Two other putative neuro-
transmitter substances present in the spinal cord are
glutamate and GABA. The present study was under-
taken to evaluate the action of these substances on
neuronal activity in intraocular spinal cord grafts.
Glutamate is an excitatory amino acid which is
present both in the dorsal and ventral gray matter of
the spinal cord/5,12/. Glutamate binding sites have
been found in the spinal dorsal horn/13/, implicating
glutamate in the transmission of afferent input to the
spinal cord. Glutamate iontophoresis near spinal
neurons results in increased neuronal activity
/8,10,37/. In the in vitro spinal cord slice preparation,
glutamate superfusion results in membrane depolari-
zation /22/ and an increase in neuronal excitability
/33/ similar to that produced by stimulation of the
attached dorsal root ganglion. It is thought that this
effect is mediated by glutamate released from primary
afferent fibers/33/, since glutamate is found in dorsal
root ganglion cells/11/. Additionally, glutamate-like
immunoreactivity has been observed in spinal neurons
/28/; and destruction of second-order dorsal horn
neurons by anoxia results in a reduction of glutamate
in the dorsal horn /9/. These findings suggest that
glutamate may also be used by spinal cord inter-
neurons. Glutamate-like immunoreactivity has been
found in intraocular spinal cord graft neurons (Miller,
1989, personal communication) and glutamate has
been used to facilitate neuronal activity in electro-
physiological studies of intraocular spinal cord grafts
/14,18,29/. However, the effects of glutamate super-
fusion on individual spinal cord graft neurons have not
been studied previously.
Another amino acid found in the spinal cord is
GABA /12,25/. The GABA synthesizing enzyme
glhtamic acid decarboxylase (GAD) is localized in
nerve terminals /2,27/ and, after colchicine pre-
treatment, in cell bodies/3/throughout the dorsal and
ventral gray matter. The presence of GABA in
intraocular spinal cord grafts has not been established.
In the spinal cord, GABA has been implicated in post-
synaptic inhibition /8/ as well as primary afferent
depolarization after primary afferent stimulation/24/.
The synaptic mechanism of GABA function has been
studied extensively in in vitro studies of cultured spinal
cord neurons/4,35/. The effect of GABA on trans-
planted spinal neurons has not been determined. In
the present study, GABA and the GABA receptor
antagonist bicuculline were administered while
recording from individual, spontaneously active spinal
cord graft neurons. Some of the results have been
reported previously in abstract form/7/.
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METHODS
Intraocular Grafting
The intraocular gratis used in this study were trans-
planted at the same time as the grafts described in a
previous report/6/. The grafting procedure has been
described in detail/30/. Briefly, spinal cord tissue was
obtained from E14-E15 rat embryos. Timed-pregnant
rats were anesthetized with ether and sacrificed by
neck dislocation, and fetuses were removed via a
midline incision. Under a dissection microscope, fetal
spinal cord tissue was isolated and bathed in Earle’s
balanced salt solution (EBSS). Each graft contained a
hemisection of one lumbar spinal cord segment freed
from surrounding meningeal tissue. Grafts were placed
bilaterally into the anterior eye chamber of ether-
anesthetized adult rats through a small incision in the
host cornea. The grafts were viewed through the
cornea and measured several times during their first
three months in oculo. The growth curves of these
grafts were similar to those reported previously/15/.
Only large, well vascularized grafts were used for
recording experiments. Recordings were made 7-9
months after transplantation. Since consistent effects
were obtained with each drug tested, it was concluded
that no significant changes related to the
pharmacology ofGABA-ergic or glutaminergic systems
occurred during this time interval.
Eiectrophysiologicai Recordings
Host rats were anesthetized with urethane (1.25 g/kg)
and tracheotomized. Body temperature and percent
expired CO2 were continuously monitored and
maintained within physiological limits. Rats were
placed in a stereotaxic apparatus and the cornea was
slit to expose the graft. A schematic drawing of the
recording and drug superfusion setup is shown in
Figure 1. A small plastic cylinder (8 mm I.D.) similar














Fig. 1: Schematic drawing of the intraocular graft recording and superfusion setup used in the rat (see text).
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around the eye. The junction between the eyeball and
the cylinder was sealed with agar. The recording
chamber was infused with EBSS at a rate of 120 gl/
min. Given the infusion rate and the volume of the
recording chamber (approximately 200/A), the
infusion chamber solution was renewed approximately
every two minutes. The EBSS was warmed by a
heating coil attached to a thermistor-controlled
feedback circuit which maintained the chamber
solution at 36C. Single-unit recordings were made
using etched carbon filament microelectrodes /1/.
Signals were amplified using conventional techniques,
and activity from single neurons was isolated with a
window discriminator. Discriminator output pulses
were used to provide audio feedback of a cell’s
discharge and to trigger a laboratory computer
(Medical Systems) that was used to construct
peristimulus time histograms.
Drug Superfusion
Superfused drugs included L-glutamic acid (Sigma),
GABA (Sigma), and bicuculline methiodide (Research
Biochemicals Inc.). Each drug was dissolved in EBSS
and delivered at room temperature via a Hamilton
50 tsl syringe as a 10 /A drop into the recording
chamber. The concentration of drug available to
individual graft neurons can only be estimated. Given
the approximate volume of EBSS in the recording
chamber (200 1), the concentration of drug at the
graft surface was approximately 1/20 that in the stock
solution. In the text and figures below, the drug
concentration in the 10/A drop is stated. While this
might not reflect the drug concentration available at
the surface of the graft, it does accurately describe the
method of superfusion used in this study.
Neurons tested for the effects of drug superfusion
had regular spontaneous firing rates when calculated
over a 30-90 sec period (see Results below). A drug
was considered effective if the average firing rate of a
neuron (calculated from a 30 sec pre-drug control
period) increased or decreased by more than 20%
during a 30, 60, or 90 see period after drug
superfusion. The onset of the drug effect was
determined by the bin-by-bin analysis of peristimulus
time histograms. The magnitude of drug effects was
calculated by comparing the neuronal activity during
the 30 sec control period to that of the 30 sec period
after the onset of each drug effect. Any changes in
firing rate of the recorded neuron after drug super-
fusion are presumed to be the result of drug action on
the entire population of graft neurons rather than a
direct effect on the neuron under study.
RESULTS
The results described below are based on single-unit
recordings of spinal cord graft neurons from twelve
intraocular grafts. Three grafts were used to study the
patterns of spontaneous activity of these neurons; no
drugs were superfused onto these grafts. Four different
grafts were used to determine the minimum
concentrations of glutamate, GABA, and bicuculline
needed to produce effects on graft neurons. Finally,
five grafts were used to study in detail the effects of
drug superfusions on spontaneous activity. An average
of four neurons was recorded from each of the twelve
grafts used in this study.
Spontaneous Activity
All neurons in this study were identified by the
presence of spontaneous activity. This activity was
easily distinguishable from that of neurons that were
ir.ritated or killed by the advancing electrode, in that
the former displayed action potentials which slowly
increased in amplitude as the microelectrode was
lowered into the graft, then remained at a relatively
constant amplitude during the time they were studied.
The s.pontaneous activity of 14 neurons was studied
in detail to determine the general discharge patterns
of spinal cord graft neurons. The mean firing rate of
each neuron evaluated over 30, 60, or 90 see intervals
was found to be relatively constant. However, the
pattern of discharge during these intervals fell into
three distinct categories. Seven of the 14 neurons had
very regular rates of activity which varied by 3 Hz or
less from their mean firing rate of 3-16 Hz. Neurons
with this pattern of activity are illustrated in Figures 2
and 5. These neurons were classified as Type A
neurons. Five neurons displayed firing patterns that
were more variable. These neurons, classified as
Type B neurons, had firing rates during a one-second
sampling period that could vary as much as 10 Hz
from their average firing rate. Two Type B neurons
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Effects of glutamate and GABA superfusions
(arrows) on the spontaneous firing rate of an
intraocular graft neuron. For this Type A neuron
(see text), 50 #M glutamate (A) increased the
firing rate 322% over the pre-drug level.
Subsequently, GABA was superfused at (B)
3 mM, (C) 15 mM, and (D) 30 mM concen-
trations, resulting in decreases in the firing rate of
this neuron of 11%, 13%, and 46%, respectively,
compared to the firing rate pre-drug. For thisand
all of the following figures: unit activity (EVENTS)
is represented on the y-axis; time in seconds on
the x-axis; the histogram bin width equals
720 msec.
are shown in Figures 3 and 4. Two other
spontaneously active neurons, Type C, fired with bursts
of 3-5 spikes every 2-5 sec. This type of neuron was
not tested for effects of drug superfusion.
Drug Concentrations
The concentrations of glutamate, GAB.A, and bicu-
culline used in this study werc determined in initial
experiments where different drug concentrations were
superfused while recording single-unit or multi-unit
activity. Data from one experiment where different
GABA concentrations were superfused are illustrated
in Figure 2. GABA effects were evaluated after
superfusion of50/aM glutamate (Fig. 2A). Subsequent
superfusion of 3 mM GABA (Fig. 2B) resulted in an
11% decrease in activity when the 30 sec pre-GABA
baseline period was compared to the 90 sec period
after GABA superfusion. Superfusion of 15 mM
GABA resulted in a 13% decrease in activity
(Fig. 2C), while superfusion of 30 mM GABA
(Fig. 2D) decreased activity by 46% compared to pre-
GABA baseline. The concentration ofbicuculline used
in this study was similarly determined in initial
experiments evaluating drug effects on single- and
multi-unit activity. In each case, superfusion of 1 mM
bicuculline did not change the spontaneous firing,
while subsequent superfusion of 2 mM bicuculline
resulted in increased neuronal activity.
Effects of Glutamate and GABA Superfusions
The effects of superfusion of L-glutamate (50/aM),
GABA (3 mM or 30 mM), or the GABA receptor
antagonist bicuculline (2 mM) were evaluated on 22
neurons. Multiple and/or repeated superfusions were
made on 11 neurons. The number of individual
neurons that were tested for drug superfusion effects
and the number of neurons that increased or
decreased their basal firing rates by at least 20%, or
were not affected, are shown in Table 1.
The effects of glutamate were evaluated on ten
neurons. Glutamate superfusion increased the firing
rates of five neurons. Figure 2A shows the effect of
glutamate superfusion on a Type A neuron. The base-
line firing rate of this neuron was 9.0 Hz. The mean
firing rate for the 60 sec period after superfusion of
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TABLE 1
SUMMARY OF DRUG SUPERFUSION EFFECTS
Effect
+ 0
Glutamate (n-- 10) 5 3 2
GABA (n= 12) 0 12 0
Bicuculline (n=8) 8 0 0
n number of tested neurons
+ increase in spontaneous activity
decrease in spontaneous activity
0 no change in spontaneous activity
50 pM glutamate was 29.0 Hz, an increase of 322%.
The firing rate returned to near baseline level by 100
see after drug superfusion. When the data were
analyzed for all neurons displaying an increase in
activity after glutamate superfusion, it was found that
the latency to these increases varied from 1-35 sec
(mean 14.2 sec) and the magnitude of the increase
varied from 165-379% of the mean baseline activity.
Increases in activity after glutamate superfusion were
observed on both Type A (n--3) and Type B (n=2)
neurons.
Glutamate administration resulted in a decrease in
activity for three neurons, even though in two cases
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Fig. 3: Histogram of the firing rate of an intraocular graft Type B neuron (see text) which exhibited a reduction in spontaneous activity
after glutamate (50 #M) superfusion (arrow). For this and all of the following figures the spike waveform generated by the neuron
under study is shown in the inset (sweep length equals 20 msec).
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Fig. 4: The effects of repeated applications (arrows) of GABA (30 mM), and the response to bicuculline (2 mM) on a Type B neuron (see
text). The first superfusion of GABA resulted in a cessation of spontaneous activity lasting 15 sec. A second superfusion of GABA
produced a silent period lasting 110 sec. Superfusion of bicuculline resulted in an initial increase, followed by a decrease in
activity. Note slow recovery of spontaneous activity following the inhibitory effect of bicuculline.
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recorded below the discriminator window. An example
of this effect on a Type B neuron is illustrated in
Figure 3. The mean firing rate of this unit decreased
from 2.4 Hz to 0.6 Hz (75%) over a 60 see period after
superfusion of 50/aM glutamate. The onset latency of
this decrease was 8 see. The mean firing rate for the
period 30 sec after the onset of effect was 1.1 Hz, a
decrease of 54%. Data from the three neurons that
reduced their firing rate after glutamate showed that
the latency of these effects varied from 8-18 sec (mean
12.7 see) while the magnitude of the decrease varied
from 37-96% of the baseline activity. All of the units
which decreased their firing rate after glutamate
superfusion were Type B neurons. Glutamate
superfusion had no effect on the firing rate of two
other Type B neurons.
In contrast to the mixed effects of glutamate,
addition of 3-30 mM GABA to the recording chamber
reduced the firing rate of all 12 neurons tested
(Table 1). Figure 4 illustrates the effects of consecutive
superfusions of GABA on a Type B neuron that had
a spontaneous firing rate of 7.4 Hz during the 30-sec
pre-drug control interval. After the first GABA super-
fusion (30 mM), this neuron stopped firing for 15 sec.
The neuron then resumed firing, initially in short
bursts, then at a near-baseline level, at which time
GABA was again administered. The second
superfusion ofGABA resulted in a longer cessation of
activity lasting 110 sec, followed by a longer period of
bursting activity before the neuron resumed firing at
near-baseline level.
The effects of GABA superfusion on spontaneous
activity were tested on four Type A and eight Type B
neurons. The latency of effects observed on this group
of neurons varied from 1-27 see (mean 9.2 sec). The
magnitude of the inhibitory effects of GABA,
calculated as above, ranged from 20-98%. Silent
periods similar to those seen in Figures 4 and 5, and
lasting at least 10 sec, were seen in 9/12 tested
neurons after GABA superfusion.
The GABA receptor antagonist bicuculline in-
creased the firing rate of all eight neurons tested. Two
different types of effects were observed following
bicuculline administration. In four cases, the excita-
tory effect of bicuculline lasted less than 60 see and
was followed by a decrease in unit activity. Figure 4
illustrates an example of this type of bicuculline effect.
In four other cases, the effect of bicuculline was long-
lasting and included the appearance of bursts of unit
firing superimposed on a neuron’s regular pattern of
activity. An example of this type of effect is shown in
Figure 5. This effect occurred following the
administration of GABA (30 mM) which produced a
long-lasting (408 see) inhibition of the cell’s
spontaneous discharge. Superfusion of bicuculline (2
mM) brought about a return of the cell’s discharge to
a level 255% above the pre-GABA control level. After
this initial burst of activity, which lasted nearly 200
see, the activity pattern of the cell consisted of
periodic bursts of spikes superimposed on a
background activity level similar to that observed
during the pre-drug control period. After a second
application of GABA, again there was a complete
cessation of the cell’s discharge lasting 184 see.
Recovery from this second GABA administration
consisted of an initial return of the bursting activity
followed by a later return to the cell’s pre-drug
discharge pattern.
Electrode Depth and Superfusion Effect
An attempt was made to determine if the variations in
latency and magnitude of effects described above were
due to differences in the depth of the recording
electrode below the graft surface. For the 10 neurons
where glutamate was superfused, the electrode depth
ranged from 159-634/am (mean 399/am). No
significant correlation was found when electrode depth
was compared to the type of glutamate effect (i.e.,
increase or decrease of spontaneous firing rate), the
latency to the glutamate effect, or the magnitude of
effect. The electrode depths for the 12 neurons studied
with GABA ranged from 94-624/am (mean
367/am). Again no significant correlation was found
between the electrode depth and either the latency or
magnitude of the GABA effect.
DISCUSSION
The technique of drug administration used in this
study was chosen as an initial means of assessing the
feasibility of studying glutamate and GABA effects on
intraocular graft neurons. We were aware of potential
problems of interpretation using this technique.
Changes in the temperature of the chamber fluid
surrounding the graft might change the spontaneous
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firing rate of a neuron independent of the effect of
superfused drugs. Furthermore, displacement of fluid
by the drug might move the graft, thereby decreasing
the amplitude of the recorded unit below the
discriminator window. Initial experiments indicated
that these were not serious problems. First, the
monitored temperature of the solution did not
noticeably change after drug superfusion. Further, in
some instances drug superfusion did not have an effect
(Table 1). Therefore it is unlikely that changes in fluid
temperature produced spurious results. As for the
possibility of pressure changes reducing the amplitude
of recorded neurons, the observed amplitudes of
action potentials did not change after drug
superfusion. Similarly, after GABA-induced silent
periods, action potentials eventually resumed which
were the same amplitude as those observed pre-drug.
Therefore the drug superfusion technique was
determined to be appropriate for this initial study of
glutamate and GABA effects on intraocular graft
neurons.
Many neurons in intraocular spinal cord grafts were
found which displayed repeated, often very regular
rates of discharge. It is thought that this activity is
generated within the graft itself, rather than as the
result of innervation from the iris /15,29/. In this
regard, spontaneously active neurons have also been
observed in cultured spinal cord neurons in vitro
/21,31,32/. In the present study we used this activity to
identify neurons prior to superfusion of glutamate,
GABA, and the GABA antagonist bicuculline.
Superfusion of the graft with glutamate had an
excitatory effect on five of ten neurons tested. The
increase in firing rate is in accordance with studies of
spinal cord neurons, where glutamate was ionto-
phoresed/8,10,37/ or applied to a spinal cord slice
preparation/22,33/. With three of ten tested neurons,
superfusion of glutamate resulted in decreases in
spontaneous firing rate. It is unlikely that this effect is
due to a direct inhibitory action of glutamate, although
such an effect has been demonstrated previously for
cerebellar interneurons /38/ studied in vitro. Rather,
the decrease in firing rate may be due to glutamate
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Effects of GABA and bicuculline superfusions (arrows) on a Type A neuron (see text). The first superfusion of GABA (30 mM)
resulted in a long-lasting inhibition of the cell’s spontaneous activity. Following bicuculline (2 mM) administra-tion there was an
initial increase in the cell’s discharge rate. Note periodic bursts of activity that were not present during the pre-drug control period
at the beginning of the histogram. A second applications of GABA produced a total inhibition of the cell’s discharge. Note
recovery of burst discharges prior to the return of the cell’s pre-drug activity level.
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the firing rate of the neuron being studied. This
explanation has previously been used to explain the
decrease in activity which is sometimes seen
subsequent to glutamate-induced neuronal excitation
/26/. Our results of a widespread effect of GABA on
graft neurons suggests that this interpretation may
apply to spinal cord grafts.
The decrease in unit firing after glutamate super-
fusion may also be due to rapid overdepolarization of
the membrane of the neuron being studied resulting in
conduction block/23/. Since a dose-response profile
of glutamate effects was not carried out, it is not
known if any of the three neurons which reduced their
spontaneous activity after glutamate superfusion would
have increased their spontaneous rate after lower
concentrations of glutamate. The concentrations of
glutamate used in this study are comparable to those
used previously in studies of glutamate administration
to the spinal cord slice /22,33/ where decreases in
activity were not seen.
Superfusion of GABA resulted in decreases in the
firing rate of all 12 spinal cord graft neurons. This
effect could be reversed by bicuculline. Similar results
were obtained when recording from spinal cord
neurons /8/ and from in vitro studies of cultured
spinal cord neurons/4,35/. These results indicate that
GABA functions in intraocular grafts, as in the spinal
cord/8,24/, to inhibit neuronal transmission.
Neurons in the present study were grouped into
three classes according to their pattern of spontaneous
activity. This has not been done in previous studies in
which responses of intraocular spinal cord graft
neurons were studied /14,15,18,29/. In the present
study only Type B neurons, which had somewhat
irregular rates of spontaneous activity, either were
unaffected or decreased their firing rate after
glutamate superfusion. It is not known whether
different neurons types described in the present study
represent neurons with different morphological
characteristics. We have previously shown that graft
neurons vary considerably in size and dendritic
organization /6/. Further studies of neuronal
responses to similar superfusions combined with
intracellular marking techniques could help determine
if there is a relationship between neuronal morphology
and the effects described in the present study.
The variability in the latency and magnitude of
effects of GABA superfusions and the independence
of these parameters on the depth of the recording
electrode, suggest that neurons in spinal cord grafts
are affected in different ways, and to different degrees,
by GABA. The superfusion technique used in this
study precluded any conclusions being made regarding
the pre- or post-synaptic action of GABA. Future
studies where GABA and GABA receptor antagonists
are administered iontophoretically while recording
neuronal activity are needed to resolve this issue.
This initial study of glutamate and GABA sensitivity
was carried out on grafts of immature rat spinal cord
transplanted to the anterior eye chamber of adult rat
hosts. An important question regarding the results
concerns changes in drug sensitivity when neurons are
in the presence of tissue that can provide afferent
input and/or an efferent target. A major target of
spinal cord projection neurons is the mesencephalon
/40/. Presently we are studying the effects of co-
grafting fetal mesencephalon with spinal cord neurons
to determine the effects of this target tissue on the
physiology and pharmacology of transplanted spinal
cord neurons.
In conclusion, the results of the present study have
shown that spinal cord graft neurons respond to
glutamate and GABA. It has previously been shown
that neurons in similar grafts display morphological
and organizational characteristics similar to those
found in situ /6/, and that graft neurons contain
several neuropeptides present in the in situ spinal cord
/16/. Further, intraocular graft neurons respond to
norepinephrine /14/ and serotonin /18/. Together,
these data suggest that the intraocular spinal cord graft
is a useful model for the study of the physiology and
pharmacology of simple neural networks in the
developing and mature spinal cord. This model may be
useful for the study ofphenomena such as denervation
supersensitivity, the influence and interaction of
multiple transmitter systems on single neurons, and
pharmacological changes that occur during the
development of ascending and descending spinal
pathways.
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